Abstract:To use solar irradiation or interior lighting efficiently, a new photocatalyst with high catalytic activity in visible light was sought. In this work, an upconversion luminescence agent, 40 CdF2·60 BaF2·1.0 Er2O3, was synthesized and its fluorescent spectrum was determined. It is found that this upconversion luminescence agent can emit five upconversion fluorescent peaks below 387nm under the excitation of 488nm visible light. The upconversion luminescence agent has revealed an improvement over ordinary titanium dioxide (TiO2) in photocatalytic activity under visible light irradiation for the photocatalytic degradation of ethyl violet in aqueous solution as a model compound. The TiO2 photocatalyst doped with upconversion luminescence agent was characterized by X-ray diffraction (XRD) and transmission electron microscope (TEM). The photocatalytic degradation of ethyl violet was tracked by UV–vis and 1H-NMR spectra, and the influences of irradiation time, initial concentration of ethyl violet, addition amount of TiO2 catalyst and initial pH value were also investigated. To affirm the complete mineralization, the total organic carbon (TOC) was also tested. The degradation rate of ethyl violet in the presence of doped rutile TiO2 photocatalyst reached 87.08% at 4.0h visible light irradiation, which was obviously higher than the corresponding degradation rate (35.42%) in the presence of undoped rutile TiO2 powder. The research results show that the upconversion luminescence agent is necessary to transform visible lights into ultraviolet lights and thus make the best use of visible lights. By calculation, the upconversion efficiency of the emission peak at 380nm was estimated to be about 0.78%. The TiO2 powder doped upconversion luminescence agent under visible light irradiation is able to decompose the ethyl violet in aqueous solution efficiently, therefore, this method may be envisaged as a technology for treating dyes wastewaters using solar energy, especially at textile industries in developing countries.

Experimental Research on the PDT Vitro Inactivation of HL60 Cells Based on Fluorescence Resonance Energy Transfer Between TiO2 and CdTe Quantum Dots

Nano-cerium-element-doped titanium dioxide induces apoptosis of Bel 7402 human hepatoma cells in the presence of visible light

Investigation on photocatalytic degradation of ethyl violet dyestuff using visible light in the presence of ordinary rutile TiO2 catalyst doped with upconversion luminescence agent.

Photocatalytic killing effect of TiO2 nanoparticles on Ls-174-t human colon carcinoma cells

Donor-Acceptor Type Supra-Carbon-Dots with Long Lifetime Photogenerated Radicals Boosting Tumor Photodynamic Therapy

Correlation of in vitro cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in mitochondria and plasma membrane

Influence of Parameters on Photodynamic Therapy of Au@TiO2–HMME Core-Shell Nanostructures

UV-enhanced Cytotoxicity of CdTe Quantum Dots in PANC-1 Cells Depend on Their Size Distribution and Surface Modification.

Size-Controllable Enhanced Energy Transfer from an Amphiphilic Conjugated−Ionic Triblock Copolymer to CdTe Quantum Dots in Aqueous Medium

Boosting the Photodynamic Therapy Efficiency with a Mitochondria-Targeted Nanophotosensitizer

Fluorescence Resonance Energy Transfer Between CdTe Quantum Dots and Copper Phthalocyanine

Forster Resonance Energy Transfer in A Hybrid System of Cdte Quantum Dots-Rhb

Molecular Engineering Design of Enhanced Donor-Acceptor Therapeutic Reagent for Efficient Image-Guided Photodynamic Therapy

Enhanced photodynamic therapy of mixed phase TiO2(B)/anatase nanofibers for killing of HeLa cells

Near Infrared-Assisted Fenton Reaction for Tumor-Specific and Mitochondrial DNA-targeted Photochemotherapy.

Carbon quantum dots/Bi4O5Br2 photocatalyst with enhanced photodynamic therapy: killing of lung cancer (A549) cells in vitro

Utilizing Dual-Pathway Energy Transfer in Upconversion Nanoconjugates for Reinforced Photodynamic Therapy

Paget's disease of the lumbar spine.

Effect of a New Photosensitizer CDHS801 Mediated Photodynamic Therapy on Bladder Cancer T24 Cell

Au Nanoclusters and Photosensitizer Dual Loaded Spatiotemporal Controllable Liposomal Nanocomposites Enhance Tumor Photodynamic Therapy Effect by Inhibiting Thioredoxin Reductase

Cell Damage Induced By Photocatalysis Of Tio2 Thin Films